BURNING ROCK BIOTECH LTD's ticker is BNR and the CUSIP is 12233L107. A total of 38 filers reported holding BURNING ROCK BIOTECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,719 | -55.5% | 20,329 | 0.0% | 0.00% | – |
| Q2 2023 | $44,317 | -22.4% | 20,329 | 0.0% | 0.00% | – |
| Q1 2023 | $57,124 | -12.2% | 20,329 | -29.7% | 0.00% | – |
| Q4 2022 | $65,090 | -27.7% | 28,929 | -23.0% | 0.00% | – |
| Q3 2022 | $90,000 | -83.5% | 37,561 | -80.0% | 0.00% | -100.0% |
| Q2 2022 | $546,000 | -26.5% | 187,539 | +351.3% | 0.00% | 0.0% |
| Q3 2021 | $743,000 | +121.1% | 41,559 | +232.8% | 0.00% | – |
| Q1 2021 | $336,000 | +25.4% | 12,487 | +17.0% | 0.00% | – |
| Q3 2020 | $268,000 | – | 10,677 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 217,728 | $5,030,000 | 2.29% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,685,908 | $38,944,000 | 2.07% |
| Casdin Capital, LLC | 1,922,150 | $44,402,000 | 1.32% |
| Orbimed Advisors | 4,161,675 | $96,135,000 | 0.84% |
| INDUS CAPITAL PARTNERS, LLC | 144,580 | $3,340,000 | 0.52% |
| Aspex Management (HK) Ltd | 486,418 | $11,236,000 | 0.44% |
| HSG Holding Ltd | 212,121 | $4,900,000 | 0.41% |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 15,100 | $349,000 | 0.39% |
| HAMILTON LANE ADVISORS LLC | 44,416 | $1,026,000 | 0.38% |
| Monashee Investment Management LLC | 80,000 | $1,848,000 | 0.24% |